Literature DB >> 11217817

Prevention in liver disease.

M R Arguedas1, M B Fallon.   

Abstract

Prevention has become an important component of medical therapy for a variety of diseases. Preventive strategies in liver disease are relatively underdeveloped and have focused mainly on specific complications of chronic liver disease and vaccination for viral hepatitis. Although public health initiatives designed to prevent certain forms of liver disease are in place, they seem to be underutilized and their utility has not been evaluated. The development of a comprehensive approach using public health initiatives in conjunction with strategies by health care providers is important because of the potential for decreasing the human and health care costs associated with hepatic dysfunction. This article reviews the available literature regarding prevention for health care providers, includes a summary of ongoing public health initiatives, and suggests an approach to prevention in liver disease. It is intended to raise awareness and encourage implementation of preventive strategies in hepatology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11217817     DOI: 10.1097/00000441-200102000-00006

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  2 in total

1.  Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults.

Authors:  Ting Wu; Shou-Jie Huang; Feng-Cai Zhu; Xue-Feng Zhang; Xing Ai; Qiang Yan; Zhong-Ze Wang; Chang-Lin Yang; Han-Min Jiang; Xiao-Hui Liu; Meng Guo; Hai-Lian Du; Mun-Hon Ng; Jun Zhang; Ning-Shao Xia
Journal:  Hum Vaccin Immunother       Date:  2013-07-25       Impact factor: 3.452

2.  Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial.

Authors:  Lun-Gen Lu; Min-De Zeng; Yi-Min Mao; Ji-Qiang Li; Mo-Bin Wan; Cheng-Zhong Li; Cheng-Wei Chen; Qing-Chun Fu; Ji-Yao Wang; Wei-Min She; Xiong Cai; Jun Ye; Xia-Qiu Zhou; Hui Wang; Shan-Ming Wu; Mei-Fang Tang; Jin-Shui Zhu; Wei-Xiong Chen; Hui-Quan Zhang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.